RFK Jr. Slashes U.S. Childhood Vaccine Schedule by 40%—Here's What Changes and Why Experts Are Alarmed

When the Centers for Disease Control and Prevention abruptly slashed America’s childhood vaccine schedule from 18 diseases down to 11, it marked what experts are calling the most dramatic weakening of vaccine recommendations in modern U.S. history. The new guidelines, which took effect immediately, now mirror Denmark’s approach—removing protections against flu, COVID-19, RSV, chickenpox, hepatitis A, rotavirus, and certain types of meningitis from the universal recommendation list. What’s alarming public health officials isn’t just the cuts themselves, but how they happened: with virtually no scientific transparency, no peer-reviewed studies cited, and a process that sidelined the traditional expert committees that have guided vaccine policy for decades.

The Scope of the Change

Under the overhaul, children will still be universally recommended to receive vaccines for 11 diseases: measles, mumps, rubella, polio, pertussis (whooping cough), tetanus, diphtheria, Haemophilus influenzae type B, pneumococcal disease, HPV, and chickenpox.

The vaccines that have been downgraded fall into two new categories:

What to watch for:

• RSV and influenza moved from universal to “high-risk groups only”—despite most hospitalized children being previously healthy
• Hepatitis A, B, dengue, and certain meningitis vaccines now “high-risk” recommendations
• Rotavirus, flu, hepatitis A and B, and meningitis now require “shared clinical decision-making” between parents and doctors
• COVID-19 vaccine already transitioned to shared decision-making last year

The shift doesn’t prevent parents from continuing to vaccinate their children against all 18 diseases—insurance will continue covering the shots, and they remain available. But the psychological and practical impact could be significant. When the CDC stops universally recommending a vaccine, fewer parents get it, fewer doctors push for it, and disease rates historically climb.

Why Experts Say This Lacks Scientific Rigor

The most damning criticism isn’t about which vaccines were cut, but how the decision was made.

Dr. Yvonne Maldonado, a Stanford University professor of global health and infectious diseases, described an “incredible lack of transparency.” She noted that the CDC’s scientific assessment contained no cited data, no peer-reviewed papers, no documented discussions—nothing explaining who made these decisions or why. Maldonado would know: she was fired from the CDC’s Advisory Committee on Immunization Practices (ACIP) in June, along with 16 colleagues including infectious disease expert Dr. Helen Chu, after Health Secretary Robert F. Kennedy Jr. replaced the panel with members largely skeptical of vaccines.

Traditionally, the ACIP—a committee of independent experts—reviews the childhood vaccine schedule annually and updates it based on the latest evidence. That process has been bypassed entirely.

“There are no data, no papers, no discussions at all that are cited,” Maldonado said. “So we have no idea who made these decisions and why they were made now.”

Dr. Helen Chu called the change “alarming, unnecessary, and will endanger the health of children in the United States.” Dr. David Margolius, Cleveland’s director of public health, echoed the concern: “There’s no rigor or reason to reduce the number of shots just because another country did it. It just doesn’t make sense.”

The Denmark Problem: Apples and Oranges

The pivot to Denmark’s schedule raises a fundamental question: why should America model its vaccine recommendations on a country with vastly different public health infrastructure, population size, disease burden, and healthcare access?

Denmark has 6 million people. The United States has over 330 million. As one expert put it, using Denmark as a template is “like cutting Ohio in half and determining which infections we should vaccinate against based on half the population of Ohio.”

But the differences go much deeper than population size.

Denmark’s advantages that the U.S. lacks:

• Universal, free healthcare with robust disease surveillance systems
• Higher public trust in health institutions (trust that wasn’t eroded by a politicized pandemic response)
• More homogeneous population with lower baseline rates of certain infectious diseases
• Systematic screening of pregnant women for hepatitis B, ensuring at-risk newborns get vaccinated

The hepatitis B example is telling. Denmark can afford to recommend the vaccine only for high-risk groups because the country has the infrastructure to test all pregnant women and catch cases before birth. When the CDC tried a similar approach in the U.S., it failed to cut infection rates in children. The American healthcare system is fragmented, millions lack consistent access to preventive care, and disease burden is higher.

Anders Peter Hviid, the senior author of a major Danish study on vaccine safety and a professor at Denmark’s equivalent of the CDC, warned that removing recommendations will “likely lead to lower uptake, leaving more children exposed to infectious disease, both among those that choose not to get vaccinated and those too young or in vulnerable populations that depend on indirect protection through herd immunity.”

Notably, Denmark itself is reconsidering its schedule. Meeting summaries from Denmark’s Vaccine Council in November 2024 show growing interest in adding back rotavirus, chickenpox, and hepatitis B vaccinations. In October, Denmark began recommending RSV vaccination for pregnant women—a move the U.S. just made harder by downgrading infant RSV shots to “high-risk” status.

The Aluminum Argument and Anti-Vaccine Ideology

The pathway to this decision reveals the influence of anti-vaccine ideology on policy.

In December, Dr. Tracy Beth Hoeg, the acting director of the FDA’s Center for Drug Evaluation and Research and a critic of COVID vaccines, presented Denmark’s schedule to a CDC advisory committee. Her presentation highlighted a talking point popular in anti-vaccine circles: that vaccines contain aluminum, an ingredient used to boost immune response, and that reducing vaccines might reduce aluminum exposure.

A major study published in July by Danish researchers found that aluminum from vaccines poses no harm. Health Secretary Kennedy demanded the journal retract the study, calling it “a deceitful propaganda stunt by the pharmaceutical industry.” The journal refused.

Kennedy, who has long claimed—falsely—that American children receive as many as 90 vaccine doses before age 18, has made limiting childhood vaccines a cornerstone of his health agenda. Shortly after Hoeg’s presentation, President Trump directed health officials to align U.S. recommendations with other developed countries’ “best practices.” Within weeks, the new schedule was announced.

The Real-World Risks

The concern among infectious disease experts isn’t hypothetical. Downgrading vaccines from universal to “high-risk only” or “shared decision-making” has predictable consequences.

Take RSV and influenza. Maldonado pointed out that the vast majority of children hospitalized with these diseases are previously healthy—they have no identifiable “risk factor” that would prompt a parent to opt in. By making these vaccines optional rather than routine, the recommendation creates a false impression that healthy kids don’t need them.

Similarly, hepatitis B vaccination of newborns within 24 hours of birth protects against a disease with no cure and serious long-term consequences. Last month, the CDC rolled back that recommendation, a move experts warned could trigger a resurgence of infections.

What Actually Changes for Families

In practical terms, the immediate impact may be limited. Insurance will continue covering all vaccines previously recommended. Parents who want their children fully vaccinated can still get them. Many pediatricians will likely continue recommending the full schedule out of habit and professional judgment.

But the long-term effects could be substantial. Each time a vaccine moves from universal recommendation to optional, uptake drops. Lower vaccination rates mean more children vulnerable to disease. And vulnerable children—infants too young to be vaccinated, immunocompromised kids, those in under-resourced communities—depend on herd immunity to stay protected.

Dr. Ofer Levy, director of the Precision Vaccines Program at Boston Children’s Hospital, noted there’s “some logic” to examining other countries’ approaches, but lamented the lack of transparency: “I wish they would have convened the FDA and the CDC committees to discuss this approach. Because not all of this was really hashed out in a discussion that was available for the public to listen to and participate in.”

The Bigger Picture

This overhaul represents something larger than vaccine policy: it’s the introduction of political ideology into medical recommendations that have historically been guided by scientific evidence. As Margolius warned, the worst-case scenario is “that this causes more confusion, more distrust, lower vaccination rates, and then just this trend of political parties and ideologies determining which vaccines people should get.”

The best-case scenario, he added, is “that nothing will change”—that doctors and parents ignore the new recommendations and continue vaccinating as before. But betting on that outcome means hoping Americans will disregard official CDC guidance, which defeats the purpose of having a CDC at all.